Tumor Necrosis Factor (TNF) Inhibitors
Tumor necrosis factor (TNF) inhibitors are a group of medications designed to block the action of TNF, a protein in the body that plays a key role in inflammation. High levels of TNF are associated with various autoimmune diseases, such as rheumatoid arthritis and Crohn's disease, where the immune system mistakenly attacks healthy tissues. By inhibiting TNF, these medications help reduce inflammation, alleviate symptoms, and improve quality of life for patients. TNF inhibitors are typically administered through injections and are often used when other treatments have not been effective.
Additional Insights
-
Tumor Necrosis Factor (TNF) inhibitors are a type of medication that helps reduce inflammation in the body. They work by blocking a protein called TNF, which plays a key role in immune responses and can contribute to inflammatory diseases like rheumatoid arthritis, psoriasis, and inflammatory bowel disease. By inhibiting TNF, these drugs help lessen symptoms, improve quality of life, and reduce damage to joints and tissues. Common TNF inhibitors include Adalimumab and Etanercept, which are often used when other treatments have not been effective.